Dolby Laboratories Financial Statements
NYSE: DLBMiscellaneousMulti-Sector CompaniesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Dolby Laboratories revenue and earnings
In fiscal 2025, Dolby Laboratories generated $1.35 billion in revenue, up 5.9% from fiscal 2024. Net income was $255.0 million (-2.6% year over year), for a net margin of 18.9% versus a median of 19.9% in the prior 5 years. Gross margin was 88.1% (down from 89.0%) and operating margin 19.6%.
Diluted earnings per share came in at $2.62, down from $2.69. Over the last 5 fiscal years, DLB's revenue has grown at a 3.0% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Dolby Laboratories income statement (annual)
| Fiscal year (USD) | FY 20252025-09-26 | FY 20242024-09-27 | FY 20232023-09-29 | FY 20222022-09-30 | FY 20212021-09-24 | FY 20202020-09-25 | FY 20192019-09-27 | FY 20182018-09-28 | FY 20172017-09-29 | FY 20162016-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.35B | 1.27B | 1.30B | 1.25B | 1.28B | 1.16B | 1.24B | 1.05B | 1.08B | 1.03B |
| Revenue growth (YoY) | +5.92% | -2.00% | +3.66% | -2.14% | +10.28% | -6.43% | +17.73% | -2.37% | +5.31% | +5.68% |
| Cost of Revenue | 160.13M | 140.50M | 152.57M | 141.36M | 130.03M | 146.50M | 160.85M | 127.56M | 118.53M | 108.98M |
| Gross Profit | 1.19B | 1.13B | 1.15B | 1.11B | 1.15B | 1.02B | 1.08B | 927.04M | 961.65M | 916.76M |
| Operating Expenses | 924.04M | 874.90M | 931.42M | 905.83M | 806.84M | 796.55M | 823.69M | 743.53M | 714.51M | 684.96M |
| Research & Development | 261.79M | 263.66M | 271.52M | 261.17M | 253.64M | 239.04M | 237.87M | 236.79M | 233.31M | 219.61M |
| Selling, General & Admin | 647.24M | 604.85M | 612.84M | 634.03M | 556.83M | 555.69M | 549.26M | 507.19M | 468.35M | 464.12M |
| Operating Income | 264.96M | 258.33M | 215.75M | 206.60M | 344.39M | 218.74M | 257.08M | 183.50M | 247.13M | 231.79M |
| Interest Expense | — | — | — | 394.00K | 479.00K | 186.00K | 170.00K | 198.00K | 127.00K | 125.00K |
| Other Income (Expense) | 38.53M | 54.15M | 34.30M | 8.67M | 10.12M | 20.97M | 25.23M | 12.87M | 8.01M | 4.11M |
| Pretax Income | 303.49M | 312.48M | 250.05M | 215.28M | 354.51M | 239.72M | 282.31M | 196.37M | 255.15M | 235.90M |
| Income Tax | 46.99M | 48.16M | 48.41M | 31.38M | 36.69M | 8.10M | 26.80M | 154.07M | 48.04M | 49.50M |
| Net Income | 255.02M | 261.82M | 200.66M | 184.09M | 310.23M | 231.36M | 255.15M | 41.75M | 206.48M | 185.86M |
| Net Income growth (YoY) | -2.60% | +30.48% | +9.00% | -40.66% | +34.09% | -9.32% | +511.20% | -79.78% | +11.09% | +2.46% |
| EPS (Basic) | 2.66 | 2.74 | 2.10 | 1.84 | 3.07 | 2.30 | 2.51 | 0.40 | 2.03 | 1.85 |
| EPS (Diluted) | 2.62 | 2.69 | 2.05 | 1.81 | 2.97 | 2.25 | 2.44 | 0.39 | 2.00 | 1.81 |
| Shares Outstanding (Basic) | 95.87M | 95.54M | 95.77M | 99.99M | 101.19M | 100.56M | 101.63M | 103.38M | 101.78M | 100.72M |
| Shares Outstanding (Diluted) | 97.48M | 97.33M | 97.73M | 101.98M | 104.62M | 102.94M | 104.57M | 106.98M | 103.29M | 102.42M |
| EBITDA | 352.79M | 333.88M | 298.31M | 295.07M | 440.25M | 309.62M | 342.20M | 264.79M | 331.44M | 316.95M |
| Gross Margin | 88.13% | 88.97% | 88.26% | 88.73% | 89.85% | 87.39% | 87.04% | 87.90% | 89.03% | 89.38% |
| Operating Margin | 19.64% | 20.28% | 16.60% | 16.48% | 26.88% | 18.83% | 20.70% | 17.40% | 22.88% | 22.60% |
| Net Margin | 18.90% | 20.56% | 15.44% | 14.68% | 24.21% | 19.91% | 20.55% | 3.96% | 19.12% | 18.12% |
This table shows 10 annual periods of Dolby Laboratories's income statement, from FY 2025 back to FY 2016, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow DLB's reporting calendar. What is a income statement?